Clinical Trials Directory

Trials / Unknown

UnknownNCT04245072

Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis

Collaborative Ocular Antiangiogenic Study of Ukraine. Multicentral, Open-label, Randomized, Prospective Study of Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Central Chorioretinitis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
The Filatov Institute of Eye Diseases and Tissue Therapy · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effectiveness of antiangiogenic therapy to choroidal neovascularization secondary to central chorioretinitis.

Detailed description

The purpose of this study is to determine the effectiveness of antiangiogenic therapy to choroidal neovascularization secondary to central chorioretinitis. This study is planned as a follow-up. Patients with central chorioretinitis included in it will receive antiangiogenic therapy in accordance with the approved indications for use indicated in the instructions for the use of drugs in Ukraine. The treatment proposed in this study is based on the world experience and scientific developments of the Filatov Institute of Eye Diseases and Tissue Therapy of the NAMS of Ukraine ". Therefore, it is expected that the benefit / risk ratio in relation to the participation in this study should not be different from that described in the scientific literature and the benefits outweigh the risk. It is known that the absence of treatment in these diseases leads to an irreparable loss of central vision.

Conditions

Interventions

TypeNameDescription
PROCEDUREIntravitreal injectionIntravitreal injection of Aflibercept 2 mg (0.05 ml) or Ranibizumab 0.5 mg (0.05 ml) to the regimen pro re nata.
DIAGNOSTIC_TESTFluorescent angiographyOphthalmic examination
DIAGNOSTIC_TESTVisometryOphthalmic examination
DIAGNOSTIC_TESTRefractometryOphthalmic examination
DIAGNOSTIC_TESTSlit lamp examinationOphthalmic examination
DIAGNOSTIC_TESTOphthalmoscopyOphthalmic examination
DIAGNOSTIC_TESTOKTOphthalmic examination

Timeline

Start date
2018-03-27
Primary completion
2021-12-31
Completion
2022-01-31
First posted
2020-01-28
Last updated
2021-02-03

Locations

3 sites across 1 country: Ukraine

Source: ClinicalTrials.gov record NCT04245072. Inclusion in this directory is not an endorsement.